Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial.

Autor: Shinkai, Masaharu1 (AUTHOR), Tsushima, Kenji2 (AUTHOR), Tanaka, Shingo3 (AUTHOR), Hagiwara, Eri4 (AUTHOR), Tarumoto, Norihito5 (AUTHOR), Kawada, Ichiro6 (AUTHOR), Hirai, Yuji7 (AUTHOR), Fujiwara, Sho8 (AUTHOR), Komase, Yuko9 (AUTHOR), Saraya, Takeshi10 (AUTHOR), Koh, Hidefumi11 (AUTHOR), Kagiyama, Naho12 (AUTHOR), Shimada, Megumi13 (AUTHOR), Kanou, Daiki14 (AUTHOR), Antoku, Shinichi15 (AUTHOR), Uchida, Yujiro16 (AUTHOR), Tokue, Yutaka17 (AUTHOR), Takamori, Mikio18 (AUTHOR), Gon, Yasuhiro19 (AUTHOR), Ie, Kenya20 (AUTHOR)
Zdroj: Infectious Diseases & Therapy. Dec2021, Vol. 10 Issue 4, p2489-2509. 21p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje